{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-025893","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2025-12-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.237091+00:00","generated_at":"2026-05-16T15:16:33.313874+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"bioAffinity to present CyPath Lung data showing Stage 1A detection in challenging cases at ACS NLCRT Dec 8","bullets":["CyPath Lung identified Stage 1A lung cancer in three patients with atypical presentations.","Poster session at American Cancer Society National Lung Cancer Roundtable on Dec 8, 2025, 2:35-3:15 p.m. ET.","Chief Medical Officer Gordon Downie presenting cases from Titus Regional Hospital Lung Nodule Clinic.","Test uses flow cytometry and AI on sputum; prior study showed 92% sensitivity and 87% specificity."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-025893","json":"https://secwatch.observer/filing/0001493152-25-025893.json","markdown":"https://secwatch.observer/filing/0001493152-25-025893.md","text":"https://secwatch.observer/filing/0001493152-25-025893.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225025893/0001493152-25-025893-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225025893/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:16:33.313874+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}